Pfizer plans $465M manufacturing facility at Michigan base; China's Tsinghua University inks discovery deal with Bristol-Myers
→ Recently battling some troubling shortages in sterile injectables, Pfizer $PFE announced it’s stepping up its manufacturing game by spending $465 million on a new facility on its Portage, MI site. Commanding 400,000 square feet, construction of the new facility is planned for next spring and scheduled to wrap up in 2021, with goals to begin production by 2024. The expansion will add 450 staffers to the 2,200 Pfizer already employs at its Portage plant under the unit name Modular Aseptic Processing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.